1 / 7

Remission of Korean Non-Insulin Dependent Diabetes Mellitus through Insulin Infusion

Study on remission patterns of non-insulin dependent diabetes mellitus using continuous subcutaneous insulin infusion treatment at Konkuk University Diabetic Center. Analyzes changes in blood glucose levels, insulin dosage, hemoglobin A1c, BMI, and plasma C-peptide post-treatment.

heatherw
Download Presentation

Remission of Korean Non-Insulin Dependent Diabetes Mellitus through Insulin Infusion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Remission of Korean Non-Insulin Dependent Diabetes Mellitus by Continuous Subcutaneous Insulin Infusion Treatment Konkuk University Diabetic Center Soobong Choi, M.D. Ph.D., Sunmin Park Diabetes/Metabolism Research and Review, March, 2003

  2. Remission Pattern (Case No.) REMISSION CSII TX. (Months)

  3. Changes of blood glucose levels and total daily insulin dosage Non-Remission. Remission. (U/day) (mg/dL) INSULIN DOSE BLOOD GLUCOSE p< 0.05 p< 0.05 (wks) (wks)

  4. Changes of Blood Glucose after CSII Non-Remission. Remission. mmol/L mmol/L ** Fasting BG Post-prandial BG ### ### ### ### (wks) (wks) **Significantly different from remission group at p<0.01. ### Significantly different from the baseline at p<0.001.

  5. Changes of Hemoglobin A1c and BMI after CSII Non-Remission. Remission. % kg/m2 Hemoglobin A1c BMI ### ### (wks) (wks) ### Significantly different from the baseline at p<0.001. # p<0.05.

  6. Plasma C-Peptide after CSII Non-Remission. Remission. nmol/L nmol/L Post-prandial c-peptide Fasting c-peptide ## ## ** * * * (wks) (wks) **Significantly different from remission group at p<0.01. * p<0.05. ## Significantly different from the baseline at p<0.01.

  7. Remission and Duration Non-Remiss. Case Remission Case (yrs) Duration

More Related